Study details
Enrolling now
Dose Optimization of MDMA-Assisted Therapy for PTSD
Bronx VA Medical Center
NCT IDNCT06418178ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
60
Study length
about 4.4 years
Ages
18+
Locations
1 site in NY
About this study
This trial is testing different doses of MDMA-assisted therapy to find the best number of treatment cycles (MDMA sessions and integration sessions) for U.S. veterans with PTSD. Participants will complete one to five cycles of MDMA-AT.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Psychotherapy
- 2.Take Midomafetamine
PhasePhase 2
Primary goalPTSD Checklist for DSM-5 (PCL-5)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: PTSD Checklist for DSM-5 (PCL-5)
Secondary: Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Body systems
Psychiatry / Mental Health